CARKD, or Carbohydrate Kinase Domain Containing protein, is a member of a broader family of proteins that possess domains capable of phosphorylating various carbohydrate substrates. The carbohydrate kinase domain is critical for the enzyme's role in the metabolism of sugars, which is fundamental to cellular energy production and various biosynthetic pathways.Proteins with a carbohydrate kinase domain, such as CARKD, are often involved in the phosphorylation of sugar molecules, a key step in metabolic processes like glycolysis and gluconeogenesis. During glycolysis, glucose is converted into pyruvate, generating ATP and NADH, which are essential for cellular energy. In gluconeogenesis, the process is reversed, synthesizing glucose from non-carbohydrate precursors, which is crucial during fasting states. CARKD may catalyze the interconversion of sugar phosphates, thus playing a role in regulating the balance between these pathways.
The function of CARKD suggests it may have a role in maintaining cellular energy homeostasis, especially under conditions where cells must rapidly adjust their metabolism in response to changes in energy demand or availability of substrates. This could be particularly relevant in tissues with high metabolic rates or in cells undergoing rapid growth or division where the demand for energy and biosynthetic precursors is increased.Research into CARKD and its specific substrates and enzymatic mechanisms is essential for a deeper understanding of metabolic regulation. Insights gained from studying CARKD could contribute to knowledge about metabolic diseases, such as diabetes and metabolic syndrome, where the regulation of carbohydrate metabolism is disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin is an anti-diabetic drug that affects glucose metabolism and could indirectly influence CARKD's role in carbohydrate metabolism. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin facilitates glucose uptake and metabolism, potentially impacting pathways where CARKD is involved. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose is a glucose analog that inhibits glycolysis, potentially affecting CARKD-related metabolic pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, affects cellular metabolism and energy homeostasis, potentially impacting CARKD function. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMPK activator that influences cellular energy metabolism, potentially affecting CARKD activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPAR-gamma agonist, affecting glucose metabolism and insulin sensitivity, potentially influencing CARKD. | ||||||
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $59.00 | 2 | |
DNP uncouples oxidative phosphorylation, altering energy metabolism, which could indirectly affect CARKD. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine has been shown to affect glucose and lipid metabolism, potentially influencing CARKD activity. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
Acarbose inhibits enzymes needed to digest carbohydrates, potentially affecting CARKD's role in carbohydrate metabolism. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences insulin sensitivity and energy metabolism, potentially impacting CARKD function. | ||||||